Primary care Osteoarthritis Screening Trial (POST): a cluster randomised trial of an electronic prompt for comorbidity screening in clinical osteoarthritis consultations in primary care.

Completed

• Source

  -

  Public Title	Primary care Osteoarthritis Screening Trial (POST): a cluster randomised trial of an electronic prompt for comorbidity screening in clinical osteoarthritis consultations in primary care.
  Acronym	POST
  Source of Record URL	http://isrctn.org/ISRCTN40721988

• Trial

  -

  Health Condition(s) or Problem	Osteoarthritis
  Lay Summary	Not provided at time of registration (from ISRCTN)
  Who can enter the trial	1. Aged 45 years and over 2. Registered with the participating GP practices during the specified study period of that practice 3. Read-coded peripheral joint pain or OA consultation within the specified study period (termed the index consultation) 4. May be first, new episode, or ongoing consultation) 5. Provided full written informed consent to study participation and to further contact 6. Male & female
  Who cannot enter the trial	1. Patients who are under active care for or who have a diagnosis of depression and/or an anxiety disorder in the past 12 months 2. Vulnerable patients, including any patients on the Quality and Outcomes Framework mental health register, or those who have a diagnosis of dementia or a terminal illness 3. Patients who reside in a nursing home 4. Red flag pathology 5. Recent trauma associated with significant injury 6. Acute, red, hot swollen joint 7. Inflammatory arthropathy, crystal disease, spondyloarthropathy and polymyalgia rheumatic
  What will happen	Generalised Anxiety Disorderr-2 (GAD-2) 1. Eligible patients in the intervention arm consulting their GP for osteoarthritis or joint pain will be asked these 4 questions on depressive and anxiety symptoms during their consultation: 1.1. Modified Patient Hlth Quest 1.2. Modified Patient Health Questionnaire (PHQ-2) 2. Eligible patients in the intervention arm consulting their GP for osteoarthritis or joint pain will be asked these 4 questions on depressive and anxiety symptoms during their consultation 3. Follow up length: 12 months
  Primary aim	1. Self report measure of current pain intensity measured at baseline, 3 months, 6 months and 12 months
  Secondary Aim	1. Anxiety (GAD-7 (5)) at baseline, 3 months, 6 months and 12 months 2. Body mass index (from self reported height and weight) at baseline, 3 months, 6 months and 12 months 3. Characteristic Pain Intensity and Disability Score at baseline, 3 months, 6 months and 12 months 4. Demographics (marital status and occupation/employment details) at baseline, 3 months, 6 months and 12 months 5. Depression (PHQ-8 (4)) at baseline, 3 months, 6 months and 12 months 6. Detailed questions about pain at baseline, 3 months, 6 months and 12 months 7. Medication and health care use at baseline, 3 months, 6 months and 12 months 8. Overall quality of life (EQ5D (2) and SF-36 (3)) at baseline, 3 months, 6 months and 12 months 9. Pain Catastrophising Scale (6) at baseline, 3 months, 6 months and 12 months 10. Pain interference with daily activities at baseline, 3 months, 6 months and 12 months 11. Social support (questions taken from previous postal surveys) at baseline, 3 months, 6 months and 12 months
  Participant Information Sheet	Sorry, not currently available
  Website	Sorry, not currently available
  Recruitment Status	Completed
  Nation	England
  Location	Newcastle under Lyme

• Contact

  -

  Contact for Public Queries	Ms Jacqueline Gray Arthritis Research UK Primary Care Centre Primary Care Sciences Keele University Newcastle under Lyme ST5 5BG United Kingdom
  Contact for Scientific Queries	Sorry, not currently available